Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Brooks Laboratories Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Low
₹58.93
High
₹61.42
Price Summary
| Previous Close | ₹60.26 |
|---|---|
| Day's Range | ₹58.93 - ₹61.42 |
| Open | ₹59.55 |
| 52 Week Range | ₹36.30 - ₹116.00 |
| Volume | 16,753 |
| Market Cap | ₹0.00 |
| Previous Close | ₹60.00 |
|---|---|
| Day's Range | ₹59.00 - ₹60.51 |
| Open | ₹59.05 |
| 52 Week Range | ₹36.90 - ₹115.00 |
| Volume | 1,379 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 10.10 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 13.32 |
| TTM EPS (₹) | 4.49 |
| P/E Ratio | 4.49 |
| Book Value(₹) | 1.42 |
| PAT Margin (%) | 28.67 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 21.72 |
| Trade Value ( ₹ in Lacs) | 0.83 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 13.32 |
| TTM EPS (₹) | 4.49 |
| P/E Ratio | 4.49 |
| Book Value(₹) | 1.42 |
| PAT Margin (%) | 28.67 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 21.72 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 255.12 | 825.57 |
| Expenses | N/A | N/A |
| PBT | 26.51 | 32.28 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 26.51 | 30.52 |
About Brooks Laboratories Ltd.
| Founded | 2002 |
|---|---|
| NSE Symbol | BROOKS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,22,282.95 | 1,756.00 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,51,611.12 | 9,619.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,75,182.22 | 4,568.00 | 3,532.60 - 3,532.60 |
| Lenskart Solutions Ltd. | 1,16,411.76 | 685.70 | 0.00 - 0.00 |
| Zydus Lifesciences Ltd. | 1,16,408.70 | 1,178.40 | 835.50 - 835.50 |
| Laurus Labs Ltd. | 1,15,616.01 | 2,186.95 | 917.95 - 917.95 |
| Apollo Hospitals Enterprise Ltd. | 1,12,152.03 | 8,063.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,09,062.53 | 1,363.25 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,08,925.78 | 1,326.50 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 1,03,286.06 | 2,496.85 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Oct
28
2026
Posted on Oct 28th 2026
Morepen Laboratories - Quaterly Results
The Top line for the quarter ended September 2026 of Rs. 6779.98 millions up 83.48% from Rs. 3695.26 millions.Net Profit witnessed a 441.64% growth almost the double from Rs. 143.77 millions to Rs. 778.71 millions of same quarter last year.The company reported a good operating profit of 1184.55 millions compared to 325.76 millions of corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 6779.98 | 3695.26 | 83.48 | 12190.39 | 7608.10 | 60.23 | 16811.95 | 15545.35 | 8.15 |
| Other Income | 84.35 | 46.53 | 81.28 | 137.46 | 87.45 | 57.19 | 214.95 | 157.20 | 36.74 |
| PBIDT | 1184.55 | 325.76 | 263.63 | 2033.64 | 556.20 | 265.63 | 1335.74 | 1691.31 | -21.02 |
| Interest | 51.04 | 41.06 | 24.31 | 98.82 | 79.18 | 24.80 | 160.97 | 71.03 | 126.62 |
| PBDT | 1133.51 | 295.66 | 283.38 | 1934.82 | 487.98 | 296.50 | 1185.73 | 1620.28 | -26.82 |
| Depreciation | 96.99 | 107.02 | -9.37 | 176.78 | 185.81 | -4.86 | 293.08 | 244.42 | 19.91 |
| PBT | 1036.52 | 188.64 | 449.47 | 1758.04 | 302.17 | 481.80 | 892.65 | 1375.86 | -35.12 |
| TAX | 257.81 | 44.87 | 474.57 | 439.34 | 77.79 | 464.78 | 232.07 | 360.10 | -35.55 |
| Deferred Tax | 51.35 | 0.00 | 0.00 | 51.35 | 0.00 | 0.00 | 84.92 | 47.27 | 79.65 |
| PAT | 778.71 | 143.77 | 441.64 | 1318.70 | 224.38 | 487.71 | 660.58 | 1015.76 | -34.97 |
| Equity | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 |
| PBIDTM(%) | 17.47 | 8.82 | 98.19 | 16.68 | 7.31 | 128.19 | 7.95 | 10.88 | -26.97 |
Read More
Oct
28
2026
Posted on Oct 28th 2026
Syschem (India) - Quaterly Results
The September 2026 quarter revenue stood at Rs. 1297.93 millions, up 10.06% as compared to Rs. 1179.24 millions during the corresponding quarter last year.A meek growth of 0.74% was reported for the quarter ended September 2026 to Rs. 19.11 millions from Rs. 18.97 millions.OP of the company witnessed a marginal growth to 44.41 millions from 33.13 millions in the same quarter last year.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 1297.93 | 1179.24 | 10.06 | 2557.41 | 2446.82 | 4.52 | 6546.26 | 3862.31 | 69.49 |
| Other Income | 0.00 | 0.11 | 0.00 | 0.47 | 0.16 | 193.75 | 0.21 | 0.42 | -50.00 |
| PBIDT | 44.41 | 33.13 | 34.05 | 50.34 | 57.83 | -12.95 | 211.13 | 40.24 | 424.68 |
| Interest | 7.38 | 0.10 | 7280.00 | 12.28 | 0.49 | 2406.12 | 22.64 | 0.66 | 3330.30 |
| PBDT | 37.03 | 33.03 | 12.11 | 38.06 | 57.34 | -33.62 | 188.49 | 39.58 | 376.23 |
| Depreciation | 15.73 | 7.57 | 107.79 | 31.28 | 15.14 | 106.61 | 40.63 | 29.47 | 37.87 |
| PBT | 21.30 | 25.46 | -16.34 | 6.78 | 42.20 | -83.93 | 147.86 | 10.11 | 1362.51 |
| TAX | 2.19 | 6.49 | -66.26 | 4.35 | 6.49 | -32.97 | 38.58 | 5.52 | 598.91 |
| Deferred Tax | 2.19 | 0.00 | 0.00 | 4.35 | 0.00 | 0.00 | 38.58 | 5.52 | 598.91 |
| PAT | 19.11 | 18.97 | 0.74 | 2.43 | 35.71 | -93.20 | 109.28 | 4.59 | 2280.83 |
| Equity | 536.16 | 435.13 | 23.22 | 536.16 | 435.13 | 23.22 | 490.13 | 435.13 | 12.64 |
| PBIDTM(%) | 3.42 | 2.81 | 21.79 | 1.97 | 2.36 | -16.72 | 3.23 | 1.04 | 209.55 |
Read More
Oct
28
2026
Posted on Oct 28th 2026
FDC - Quaterly Results
The revenue for the September 2026 quarter is pegged at Rs. 5527.90 millions, about 19.72% up against Rs. 4617.40 millions recorded during the year-ago period.Handsome Net Profit growth of 61.77% reported above the corresponding previous quarter figure of Rs. 476.90 millions to Rs. 294.80 millions.Operating profit surged to 803.10 millions from the corresponding previous quarter of 558.10 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 5527.90 | 4617.40 | 19.72 | 12078.90 | 11040.20 | 9.41 | 21263.27 | 20701.12 | 2.72 |
| Other Income | 186.20 | 209.10 | -10.95 | 659.60 | 565.00 | 16.74 | 1110.01 | 1055.18 | 5.20 |
| PBIDT | 803.10 | 558.10 | 43.90 | 2704.90 | 2327.30 | 16.22 | 4631.81 | 4257.65 | 8.79 |
| Interest | 8.30 | 11.50 | -27.83 | 16.50 | 23.10 | -28.57 | 49.24 | 44.88 | 9.71 |
| PBDT | 794.80 | 546.60 | 45.41 | 2688.40 | 2304.20 | 16.67 | 4374.68 | 4212.77 | 3.84 |
| Depreciation | 159.50 | 151.70 | 5.14 | 310.40 | 300.40 | 3.33 | 591.04 | 536.06 | 10.26 |
| PBT | 635.30 | 394.90 | 60.88 | 2378.00 | 2003.80 | 18.67 | 3783.64 | 3676.71 | 2.91 |
| TAX | 158.40 | 100.10 | 58.24 | 580.90 | 487.00 | 19.28 | 924.40 | 940.46 | -1.71 |
| Deferred Tax | -5.00 | -9.90 | -49.49 | 20.50 | 27.00 | -24.07 | 61.40 | 90.46 | -32.12 |
| PAT | 476.90 | 294.80 | 61.77 | 1797.10 | 1516.80 | 18.48 | 2859.24 | 2736.25 | 4.49 |
| Equity | 162.80 | 162.80 | 0.00 | 162.80 | 162.80 | 0.00 | 162.81 | 162.81 | 0.00 |
| PBIDTM(%) | 14.53 | 12.09 | 20.20 | 22.39 | 21.08 | 6.23 | 21.78 | 20.57 | 5.91 |
Read More
Oct
28
2026
Posted on Oct 28th 2026
Indoco Remedies - Quaterly Results
A minor change in the total revenue was seen in the September 2026 quarter. The total revenue for the quarter stood at Rs. 4515.90 millions against Rs. 4421.20 millions during year ago period.The Total revenue for the quarter ended September 2026 of Rs. 306.30 millions grew by 103.52% from Rs. 150.50 millions.The company reported a degrowth in operating Profit to 452.90 millions from 599.30 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 4515.90 | 4421.20 | 2.14 | 8605.60 | 8364.30 | 2.88 | 16860.70 | 15181.90 | 11.06 |
| Other Income | 50.20 | 65.40 | -23.24 | 94.90 | 121.20 | -21.70 | 296.40 | 184.80 | 60.39 |
| PBIDT | 452.90 | 599.30 | -24.43 | 919.70 | 803.30 | 14.49 | 1867.90 | 1465.20 | 27.48 |
| Interest | 198.70 | 220.10 | -9.72 | 426.20 | 456.20 | -6.58 | 885.00 | 566.30 | 56.28 |
| PBDT | 625.60 | 373.90 | 67.32 | 1838.30 | 341.80 | 437.83 | 954.30 | 908.80 | 5.01 |
| Depreciation | 278.60 | 276.30 | 0.83 | 559.10 | 528.30 | 5.83 | 1069.00 | 982.50 | 8.80 |
| PBT | 347.00 | 97.60 | 255.53 | 1279.20 | -186.50 | -785.90 | -114.70 | -73.70 | 55.63 |
| TAX | 40.70 | -52.90 | -176.94 | 149.70 | -56.30 | -365.90 | -58.10 | 13.60 | -527.21 |
| Deferred Tax | -45.00 | -52.90 | -14.93 | -41.60 | -56.30 | -26.11 | -87.30 | 13.60 | -741.91 |
| PAT | 306.30 | 150.50 | 103.52 | 1129.50 | -130.20 | -967.51 | -56.60 | -87.30 | -35.17 |
| Equity | 184.60 | 184.50 | 0.05 | 184.60 | 184.50 | 0.05 | 184.60 | 184.50 | 0.05 |
| PBIDTM(%) | 10.03 | 13.56 | -26.01 | 10.69 | 9.60 | 11.28 | 11.08 | 9.65 | 14.79 |
Read More
Oct
28
2026
Posted on Oct 28th 2026
Acutaas Chemicals - Quaterly Results
The sales surged to Rs. 4330.48 millions, up 41.89% for the September 2026 quarter as against Rs. 3051.93 millions during the corresponding quarter previous year.Profit for the quarter ended September 2026 rises by 86.22% to Rs. 1357.36 millions from Rs. 728.91 millions.Operating Profit saw a handsome growth to 1913.87 millions from 1055.75 millions in the quarter ended September 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 4330.48 | 3051.93 | 41.89 | 7554.57 | 5111.64 | 47.79 | 13237.92 | 9898.35 | 33.74 |
| Other Income | 80.46 | 89.70 | -10.30 | 125.22 | 249.90 | -49.89 | 458.78 | 183.36 | 150.21 |
| PBIDT | 1913.87 | 1055.75 | 81.28 | 3055.40 | 1725.84 | 77.04 | 5288.83 | 2434.78 | 117.22 |
| Interest | 9.94 | 5.72 | 73.78 | 21.12 | 11.92 | 77.18 | 30.77 | 58.57 | -47.46 |
| PBDT | 1903.93 | 1050.03 | 81.32 | 3034.28 | 1713.92 | 77.04 | 5258.06 | 2376.21 | 121.28 |
| Depreciation | 93.13 | 77.22 | 20.60 | 183.33 | 151.84 | 20.74 | 330.32 | 240.45 | 37.38 |
| PBT | 1810.80 | 972.81 | 86.14 | 2850.95 | 1562.08 | 82.51 | 4927.74 | 2135.76 | 130.73 |
| TAX | 453.44 | 243.90 | 85.91 | 734.63 | 386.71 | 89.97 | 1265.99 | 540.29 | 134.32 |
| Deferred Tax | 61.19 | 50.38 | 21.46 | 87.06 | 65.91 | 32.09 | 111.09 | 70.58 | 57.40 |
| PAT | 1357.36 | 728.91 | 86.22 | 2116.32 | 1175.37 | 80.06 | 3661.75 | 1595.47 | 129.51 |
| Equity | 409.36 | 409.36 | 0.00 | 409.36 | 409.36 | 0.00 | 409.36 | 409.34 | 0.00 |
| PBIDTM(%) | 44.20 | 34.59 | 27.76 | 40.44 | 33.76 | 19.79 | 39.95 | 24.60 | 62.42 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Brooks Laboratories Ltd. is ₹60.26 as of 2026-10-28.
The market capitalisation of Brooks Laboratories Ltd. is ₹175.98 as of 2026-10-27.
The 1-year return of Brooks Laboratories Ltd. is -51.84% as of 2026-10-28.
The P/E ratio of Brooks Laboratories Ltd. is 4.49 as of 2026-10-28.
The 52-week high and low of Brooks Laboratories Ltd. are ₹116.00 and ₹36.30, respectively, as of 2026-10-28.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
